115 related articles for article (PubMed ID: 9760157)
1. Acute myelogenous leukemia (FAB AML-M1) in the setting of HIV infection and G-CSF therapy: a case report and review of the literature.
King JA; Nye DM; O'Connor MB; Sendelbach KM; Elkhalifa MY
Ann Hematol; 1998; 77(1-2):69-73. PubMed ID: 9760157
[TBL] [Abstract][Full Text] [Related]
2. Human granulocyte colony-stimulating factor receptors in acute myelogenous leukemia.
Kondo S; Okamura S; Asano Y; Harada M; Niho Y
Eur J Haematol; 1991 Apr; 46(4):223-30. PubMed ID: 1707827
[TBL] [Abstract][Full Text] [Related]
3. Successful hematopoietic reconstitution with granulocyte colony-stimulating factor in a patient with hypoplastic acute myelogenous leukemia.
Lee M; Chubachi A; Niitsu H; Miura I; Yanagisawa M; Hirokawa M; Miura AB
Intern Med; 1995 Jul; 34(7):692-4. PubMed ID: 7496088
[TBL] [Abstract][Full Text] [Related]
4. Remission induction by granulocyte colony-stimulating factor in hypoplastic acute myelogenous leukemia complicated by infection. A case report and review of the literature.
Takamatsu Y; Miyamoto T; Iwasaki H; Makino S; Tamura K
Acta Haematol; 1998; 99(4):224-30. PubMed ID: 9644302
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood and bone marrow changes after treatment with ATRA and G-CSF in AML, APL and blast crisis following Vaquez's disease.
Notario A; Rolandi ML; Mazzucchelli I
Haematologica; 1996; 81(3):261-4. PubMed ID: 8767533
[TBL] [Abstract][Full Text] [Related]
6. Acute myelogenous leukaemia and myelomonocytic blast crisis following polycythemia vera in HIV positive patients: report of cases and review of the literature.
Hentrich M; Rockstroh J; Sandner R; Brack N; Hartenstein R
Ann Oncol; 2000 Feb; 11(2):195-200. PubMed ID: 10761755
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemia.
Gandhi V; Estey E; Du M; Nowak B; Keating MJ; Plunkett W
Clin Cancer Res; 1995 Feb; 1(2):169-78. PubMed ID: 9815970
[TBL] [Abstract][Full Text] [Related]
8. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte colony-stimulating factor in acute myeloid leukemia.
Usuki K; Iki S; Endo M; Kitazume K; Ito K; Watanabe M; Urabe A
Stem Cells; 1995 Nov; 13(6):647-54. PubMed ID: 8590866
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometry measurement of GM-CSF receptors in acute leukemic blasts, and normal hemopoietic cells.
Lanza F; Castagnari B; Rigolin G; Moretti S; Latorraca A; Ferrari L; Bardi A; Castoldi G
Leukemia; 1997 Oct; 11(10):1700-10. PubMed ID: 9324292
[TBL] [Abstract][Full Text] [Related]
11. Impact on acute myeloid leukemia relapse in granulocyte colony-stimulating factor application: a meta-analysis.
Feng X; Lan H; Ruan Y; Li C
Hematology; 2018 Oct; 23(9):581-589. PubMed ID: 29516766
[TBL] [Abstract][Full Text] [Related]
12. Clinical effect of granulocyte colony-stimulating factor on neutrophils and leukemic cells in myelogenous leukemia: analysis.
Ishikawa J; Yoshimura M; Matsunashi T; Tominaga N; Teshima H; Hiraoka A; Nakamura H; Shibata H; Masaoka T; Takaku F
Jpn J Clin Oncol; 1991 Jun; 21(3):169-75. PubMed ID: 1719259
[TBL] [Abstract][Full Text] [Related]
13. Biological characteristics of CD7 positive acute myelogenous leukaemia.
Eto T; Akashi K; Harada M; Shibuya T; Takamatsu Y; Teshima T; Niho Y
Br J Haematol; 1992 Nov; 82(3):508-14. PubMed ID: 1283077
[TBL] [Abstract][Full Text] [Related]
14. Correlation between the proliferative response to granulocyte colony-stimulating factor and the positivity of transferrin receptor in acute myeloblastic leukemia cells.
Motoji T; Mineshima M; Watanabe M; Takanashi M; Masuda M; Oshimi K; Mizoguchi H
J Cell Physiol; 1991 Sep; 148(3):421-5. PubMed ID: 1717498
[TBL] [Abstract][Full Text] [Related]
15. Economic analysis of granulocyte colony stimulating factor as adjunct therapy for older patients with acute myelogenous leukemia (AML): estimates from a Southwest Oncology Group clinical trial.
Bennett CL; Hynes D; Godwin J; Stinson TJ; Golub RM; Appelbaum FR;
Cancer Invest; 2001; 19(6):603-10. PubMed ID: 11486703
[TBL] [Abstract][Full Text] [Related]
16. Effects of interleukin-6 and granulocyte colony-stimulating factor on the proliferation of leukemic blast progenitors from acute myeloblastic leukemia patients.
Suzuki T; Morio T; Tohda S; Nagata K; Yamashita Y; Imai Y; Aoki N; Hirashima K; Nara N
Jpn J Cancer Res; 1990 Oct; 81(10):979-86. PubMed ID: 1699919
[TBL] [Abstract][Full Text] [Related]
17. Haematologic and immunophenotypic profile of acute myeloid leukemia: an experience of Tata Memorial Hospital.
Ghosh S; Shinde SC; Kumaran GS; Sapre RS; Dhond SR; Badrinath Y; Ansari R; Kumar A; Mahadik S; Chougule AB; Nair CN
Indian J Cancer; 2003; 40(2):71-6. PubMed ID: 14716122
[TBL] [Abstract][Full Text] [Related]
18. Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor.
Estey E; Thall P; Andreeff M; Beran M; Kantarjian H; O'Brien S; Escudier S; Robertson LE; Koller C; Kornblau S
J Clin Oncol; 1994 Apr; 12(4):671-8. PubMed ID: 7512125
[TBL] [Abstract][Full Text] [Related]
19. Acute myelogenous leukemia in a child with HIV infection.
Tullu MS; Date NB; Ghildiyal RG; Modi CJ
Eur J Pediatr; 2010 May; 169(5):629-31. PubMed ID: 19802631
[TBL] [Abstract][Full Text] [Related]
20. CD117/CD34 expression in leukemic blasts.
Wells SJ; Bray RA; Stempora LL; Farhi DC
Am J Clin Pathol; 1996 Aug; 106(2):192-5. PubMed ID: 8712172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
